Project Grant K01HL177176
Award Date 8/25/25
Completion Date 7/31/28
Dollars Obligated $186K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Oregon, USA
Similar Awards
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $774,229 Project Grant under CFDA 93.837 - Cardiovascular Diseases Research to the Kaiser Foundation Hospitals in Oakland, CA. The grant, titled "Understanding the Impact of Early Life Factors on Cardiometabolic Risk Throughout the Life Course in a Large and Diverse Cohort of Adolescents and Young Adults", aims to conduct a large longitudinal cohort study to better understand the epidemiology of cardiometabolic outcomes...
- The University of Chicago was awarded a $275,196 federal Project Grant from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) on September 23, 2025. The grant will support research focused on understanding the impact of adolescent reproductive health factors on the risk of cardiometabolic disease in young adult women. The research will leverage longitudinal data from the Pittsburgh Girls Study to examine associations between pubertal, sexual, and...
- The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), awarded a $392,037 Project Grant to New York University (NYU) to support research on post-operative biomarker-guided precision medicine for cardiovascular risk reduction. The goal is to carry out an international multi-site randomized clinical trial to evaluate perioperative biomarker-based precision care, using targeted long-term use of low-dose direct oral anticoagulants and...
- This $165,364 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research by the Broad Institute, Inc. to identify novel contextual and genomic blood pressure (BP) measures to enhance cardiovascular disease (CVD) prediction and management in young adults aged 18-39. The key products and services to be delivered under this 2-year award include: Identifying novel ambulatory BP patterns capturing...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $304,415 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Pulseimaging.ai, LLC, located in Cleveland, Ohio. The purpose of the grant is to develop a software solution to improve cardiovascular risk prediction using artificial intelligence (AI) and image analytics on coronary calcium score screening CT scans. The project aims to create an AI-based approach that can better predict future cardiovascular...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $232,498 Project Grant to Emory University under the Cardiovascular Diseases Research (CFDA 93.837) program. The grant supports the use of natural language processing and machine learning techniques to analyze electronic health records and develop a risk prediction model for Fontan failure in patients with rare single ventricle heart defects. The goal is to improve detection of multi-organ comorbidities and define physiologic...
- The National Heart, Lung, and Blood Institute (NHLBI) has awarded a $751,124 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Kaiser Foundation Hospitals in Pleasanton, CA. The grant supports research to explore the timing and intensity of physical activity, as well as the optimal 24-hour activity compositions, for the prevention of hypertensive disorders of pregnancy, which impact 10-15% of pregnancies and are risk factors for future cardiovascular disease in...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded a $167,588 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Icahn School of Medicine at Mount Sinai (ISMMS). This 5-year grant, awarded on March 1, 2025, supports the development and validation of predictive tools using deep learning to assess right ventricular size, function, and outcomes in patients with repaired tetralogy of Fallot. The key products and services to be delivered include: 1) A...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) provides $763,858 to Brigham & Women's Hospital, a subsidiary of the Partners Healthcare System, to assess the impact of improving cardiovascular disease (CVD) care for adults with diagnosed diabetes in diverse global settings. The project aims to develop a cardiovascular simulation model, PREDICT-DM, and use it to evaluate the clinical impact, costs, and...
- The National Heart, Lung, and Blood Institute (NHLBI) has awarded a $136,646 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Duke University to conduct an observational study on sex differences in physical activity (PA) participation during and after cardiac rehabilitation (CR) programs. The study aims to: 1) Identify sex differences in PA participation during and after CR, 2) Determine sex-specific barriers to PA, and 3) Examine key predictors of PA...